Equities researchers at Brookline Capital Management initiated coverage on shares of Envoy Medical (NASDAQ:COCH – Get Free Report) in a research report issued on Monday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $9.00 price target on the stock. Brookline Capital Management’s price target would indicate a potential upside of 257.14% from the stock’s current price.
Separately, Ascendiant Capital Markets raised their price target on shares of Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a report on Tuesday, September 3rd.
View Our Latest Analysis on Envoy Medical
Envoy Medical Stock Up 3.3 %
Envoy Medical (NASDAQ:COCH – Get Free Report) last released its earnings results on Monday, August 12th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The company had revenue of $0.07 million for the quarter, compared to the consensus estimate of $0.08 million. On average, research analysts forecast that Envoy Medical will post -1.22 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Envoy Medical
An institutional investor recently bought a new position in Envoy Medical stock. WealthTrust Asset Management LLC purchased a new position in Envoy Medical, Inc. (NASDAQ:COCH – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 11,316 shares of the company’s stock, valued at approximately $44,000. WealthTrust Asset Management LLC owned about 0.06% of Envoy Medical as of its most recent SEC filing. 8.59% of the stock is owned by institutional investors and hedge funds.
Envoy Medical Company Profile
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
Recommended Stories
- Five stocks we like better than Envoy Medical
- Top Biotech Stocks: Exploring Innovation Opportunities
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- The Basics of Support and Resistance
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.